Researchers have managed to reverse some of the damage caused by a heart attack using stem cells that were induced from connective tissue cells, according to a study published Monday.
Madison stem cell firm Cellular Dynamics International Inc. said Wednesday it has licensed a pair of patents that will advance its effort to mass produce stem cell-derived cells for pharmaceutical companies.
Neuralstem (CUR) will sponsor stem cell research at the China Medical University & Hospital of Taiwan. The work will help prepare for a human clinical trial using Neuralstem’s human spinal cord neural stem cells to treat patients who have suffered a stroke.
Bioheart, Inc, announced that they would be going into the final phase of clinical trial with muscle stem cell in cardiovascular disease treatment.
Wonders may not cease where stem cell treatment is concerned. Recently stem cell treatment has been applied on human, as a case of Phase I trial and the doctors are quite optimistic since it has been successful in animals.
LOWERING of ejection fraction of heart is a serious case in heart patients. Often people suffer from breathing problems and low heart rate due to lowering of ejection fraction of heart after a person experiences a cardiac attack. But stem cell once again hovered its magic stick round, and it has been seen that regeneration of new heart muscles and veins has improved the percentage about 30%.